Fed. Circ. Affirms Warner Chilcott's Actonel Patents Invalid
The Federal Circuit on Tuesday ruled that two patents for Warner Chilcott Co. LLC's osteoporosis drug Actonel were invalid as obvious, affirming a lower court decision in favor of generic-drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article